Home › Funds › CHILTON CAPITAL MANAGEMENT LLC › GILD

CHILTON CAPITAL MANAGEMENT LLC position in GILD

GILEAD SCIENCES INC · Health Care

CHILTON CAPITAL MANAGEMENT LLC reported holding 410,321 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$61.2M, representing 1.94% of its reported portfolio and ranking #14 among its reported holdings. CHILTON CAPITAL MANAGEMENT LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)410.32K sh
Reported value held$61.16M
Portfolio Weight1.94%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CHILTON CAPITAL MANAGEMENT LLC's GILD position evolved

CHILTON CAPITAL MANAGEMENT LLC first disclosed a stake in GILD in Q3 2023 at 3,065 shares (US$230K). The position peaked in Q3 2026 at 410,321 shares, worth US$61.2M. Across 13 filings, CHILTON CAPITAL MANAGEMENT LLC increased the stake 8 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 410,321 shares valued at US$61.2M. Notable position changes include a 95% trim in Q2 2024 (shares rose 22% over the following quarter), a 125739% increase in Q1 2025 (shares were roughly flat over the following quarter), a 58% increase in Q2 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.06K $229.69K New
Q4 2023 3.09K $250.08K Add
Q1 2024 3.09K $226.12K Hold
Q2 2024 165 $11.32K Reduce
Q3 2024 185 $15.51K Add
Q4 2024 187 $17.27K Add
Q1 2025 235.32K $26.37M Add
Q2 2025 372.85K $41.34M Add
Q3 2025 441.46K $49.00M Add
Q4 2025 484.52K $59.47M Add
Q1 2026 401.75K $55.99M Reduce
Q2 2026 411.73K $52.02M Add
Q3 2026 410.32K $61.16M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has CHILTON CAPITAL MANAGEMENT LLC held GILD?

CHILTON CAPITAL MANAGEMENT LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CHILTON CAPITAL MANAGEMENT LLC's current position in GILD?

As of Q3 2026, CHILTON CAPITAL MANAGEMENT LLC holds 410.32K shares of GILD (GILEAD SCIENCES INC), valued at $61.16M, representing 1.94% of its reported portfolio and ranking #14.

Has CHILTON CAPITAL MANAGEMENT LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), CHILTON CAPITAL MANAGEMENT LLC held unchanged its position in GILD. The position peaked in Q3 2026 at 410.32K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.